Ophthalmic manifestations and treatments of proteus syndrome: a case report and systematic review

被引:1
作者
Jia, R. -B. [1 ,2 ]
Wang, Y. -F. [1 ,2 ]
Jia, R. -B. [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai, Peoples R China
[2] Shanghai Key Lab Orbital Dis & Ocular Oncol, Shanghai, Peoples R China
基金
中国博士后科学基金;
关键词
Proteus syndrome; Ocular; Ophthalmic manifesta-tions; Ophthalmic treatments; Endoscope-navigation system (ENS); PATHWAY RETRACTION; BREAST-CANCER; AKT1; PHENOTYPE; PROMOTES; MUTATION; FEATURES; PATIENT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
- BACKGROUND: Proteus syndrome (PS) is an extremely rare disorder with ocular manifestations. In this study, we aimed to describe the ophthalmic characteristics and the clinical course of an unusual PS patient to acquire a comprehensive and intensive understanding of ocular PS and highlight the importance of collaborative treatment by ophthalmologists. CASE PRESENTATION: A case of PS with atypical ocular features and syndromes was observed in a Chinese female. Her proptosis and vision impairment were relieved after Endoscope-Navigation system (ENS)-aided optic canal decompression. A 1.5-year follow-up showed that the treatment was temporarily effective, but the disease continued to develop. A review of the literature was conducted: forty-eight patients met the inclusion criteria. Although ocular manifestations play important roles in PS diagnosis, only a limited number of cases have been reported to have ocular abnormalities. And to date, almost none of these reports have described the treatment in detail. Therefore, PS patients with ocular manifestations were reviewed. CONCLUSIONS: PS is a complex disorder with variable characteristics and progressive imbalances. In this paper, the clinical symptoms, molecular characteristics, and differential diagnosis of PS are introduced. More importantly, the ocular manifestations, treatment, and prognosis of PS cases to date are summarized and discussed. This study aimed to acquire a comprehensive and intensive understanding of ocular PS and to reveal the importance of collaborative treatment by ophthalmologists.
引用
收藏
页码:10313 / 10321
页数:9
相关论文
共 72 条
[31]   Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer [J].
Herberts, Cameron ;
Murtha, Andrew J. ;
Fu, Simon ;
Wang, Gang ;
Schonlau, Elena ;
Xue, Hui ;
Lin, Dong ;
Gleave, Anna ;
Yip, Steven ;
Angeles, Arkhjamil ;
Hotte, Sebastien ;
Tran, Ben ;
North, Scott ;
Taavitsainen, Sinja ;
Beja, Kevin ;
Vandekerkhove, Gillian ;
Ritch, Elie ;
Warner, Evan ;
Saad, Fred ;
Iqbal, Nayyer ;
Nykter, Matti ;
Gleave, Martin E. ;
Wang, Yuzhuo ;
Annala, Matti ;
Chi, Kim N. ;
Wyatt, Alexander W. .
EUROPEAN UROLOGY, 2020, 78 (06) :834-844
[32]   Distinct functions of AKT isoforms in breast cancer: a comprehensive review [J].
Hinz, Nico ;
Juecker, Manfred .
CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)
[33]   Histopathological features of Proteus syndrome [J].
Hoey, S. E. H. ;
Eastwood, D. ;
Monsell, F. ;
Kangesu, L. ;
Harper, J. I. ;
Sebire, N. J. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (03) :234-238
[34]  
Hong Jin Hwa, 2010, J Pediatr Adolesc Gynecol, V23, pe107, DOI 10.1016/j.jpag.2009.08.010
[35]   Proteus syndrome with sciatic nerve fibrolipomatous hamartoma: an uncommon finding in a rare disease: report of two cases with literature review [J].
Ibrahim, Dalia .
BJR CASE REPORTS, 2022, 8 (02)
[36]   Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome [J].
Keppler-Noreuil, Kim M. ;
Lozier, Jay ;
Oden, Neal ;
Taneja, Anjali ;
Burton-Akright, Jasmine ;
Sapp, Julie C. ;
Biesecker, Leslie G. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2019, 181 (04) :571-581
[37]   A Severe and Rapidly Progressive Case of Proteus Syndrome in a Neonate Who Presented with Unilateral Hydrocephalus Apart from Other Typical Features of the Proteus Syndrome [J].
Kumar, Rakesh ;
Bhagat, Puja .
JOURNAL OF CLINICAL NEONATOLOGY, 2012, 1 (03) :152-154
[38]  
Lal Niharika R, 2015, Indian Dermatol Online J, V6, P348, DOI 10.4103/2229-5178.164477
[39]  
Lei Y, 2021, EUR REV MED PHARMACO, V25, P2460, DOI [10.26355/eurrev_202103_25398, 10.26355/eurrev_202103_25400]
[40]   What is the Main Potential Factor Influencing Ocular Protrusion? [J].
Li, Yinwei ;
Su, Yun ;
Song, Xuefei ;
Zhou, Huifang ;
Fan, Xianqun .
MEDICAL SCIENCE MONITOR, 2017, 23 :57-64